Thiazolidinediones considered in T2DM management update

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1617, 2007-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thiazolidinediones considered in T2DM management update

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 543, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Contemporary issues in T2DM management

Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Current and Future Treatment Directions in T2DM

Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Pioglitazone improves measures of T2DM and dyslipidaemia

Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

ACP guideline on oral therapy for T2DM

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 648, 2012-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite